PROCEPT BioRobotics Corporation
PRCT
$21.65
-$0.30-1.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.34% | 20.20% | 11.94% | 42.76% | 48.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.34% | 20.20% | 11.94% | 42.76% | 48.41% |
| Cost of Revenue | 17.07% | 16.74% | 22.41% | 36.64% | 25.44% |
| Gross Profit | 20.55% | 22.16% | 6.05% | 46.31% | 64.37% |
| SG&A Expenses | 23.74% | 17.92% | 20.66% | 38.23% | 37.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.24% | 19.81% | 22.15% | 31.84% | 26.43% |
| Operating Income | -23.44% | -18.84% | -57.49% | -3.41% | 17.29% |
| Income Before Tax | -37.68% | -27.83% | -60.40% | -2.08% | 24.13% |
| Income Tax Expenses | -30.88% | 8.51% | -48.37% | -- | -- |
| Earnings from Continuing Operations | -37.20% | -27.90% | -58.28% | -2.08% | 23.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.20% | -27.90% | -58.28% | -2.08% | 23.60% |
| EBIT | -23.44% | -18.84% | -57.49% | -3.41% | 17.29% |
| EBITDA | -23.30% | -18.90% | -60.66% | -2.25% | 19.40% |
| EPS Basic | -33.31% | -24.31% | -52.00% | 4.74% | 28.87% |
| Normalized Basic EPS | -33.76% | -24.21% | -54.05% | 4.72% | 29.36% |
| EPS Diluted | -33.31% | -24.31% | -52.00% | 4.74% | 28.87% |
| Normalized Diluted EPS | -33.76% | -24.21% | -54.05% | 4.72% | 29.36% |
| Average Basic Shares Outstanding | 2.93% | 2.90% | 4.15% | 7.14% | 7.41% |
| Average Diluted Shares Outstanding | 2.93% | 2.90% | 4.15% | 7.14% | 7.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |